National Institutes Of Health
The White House unveiled a national plan in September to combat antibiotic-resistant bacteria. It includes an executive order to "reduce the emergence and spread" of these bacteria and ensure availability of treatments.
The Obama administration has unveiled a national strategy to combat antibiotic-resistant bacteria. It includes an executive order to direct the federal government to "reduce the emergence and spread of antibiotic-resistant bacteria and to help ensure the continued availability of effective treatments for bacterial infections."
The number of people with long-term care needs is set to triple by 2050, and dementia care will be increasingly at the forefront for providers, according to a new report from Alzheimer's Disease International.
More than 110 million Americans watched yesterday's Super Bowl in New Orleans. It's not too hard to see why the game has become our nation's defining cultural ritual. The National Football League also could give us the nation's best chance at progress against Alzheimer's disease.
Older women with disturbed and fragmented sleep were three times more likely to be placed in a long-term care facility than elderly women with healthier sleep patterns, new research finds.
The House Appropriations Subcommittee passed a draft 2013 spending bill Wednesday that dramatically slashes healthcare outlays.
The aging of the American population and the healthcare issues that go with it are creating a demographic earthquake that will shake our current system of healthcare to the core. We are on our way to becoming a nation of caregivers, a job description we are largely unprepared to fill.
The $80 million President Obama designated to Alzheimer's research could have more strings attached to it than previously thought, a key senator has said.
More seniors with kidney disease should be put on transplant lists, according to a Johns Hopkins researcher. Attitudes based on outdated outcomes instead appear to be keeping seniors off transplant lists, he said.
New diagnostic criteria and new biomarkers for Alzheimer's disease should go a long way in helping physicians catch the disease earlier and develop therapies faster, according to new guidelines released by the Alzheimer's Association and the National Institutes of Health and the National Institute of Aging.
An independent panel of medical experts has determined that there is no strong scientific evidence to support several measures for the prevention of cognitive decline and Alzheimer's disease.